Sanofi S.A. (SNY)
Coverage summary
Aardvark Labs Capital Research has covered Sanofi S.A. (SNY) since April 24, 2026. The company is in the Healthcare sector. This page lists 3 reports: 3 earnings recaps.
The latest is the Q3 2026 Earnings Recap, published October 31, 2026. The current rating is Hold, the same in every report since coverage began.
Translations: 2 in Chinese.
All SNY reports
2026-10-31
Recap: Q3 2026
Sanofi Raises Earnings Again, but the Post-Dupixent Bridge Still Needs Numbers
2026-07-31
Recap: Q2 2026
Beat, Raise, Sell-Off: Sanofi Cuts Three Programmes and Concedes the 2031 Base Case
2026-04-24
Recap: Q1 2026
A 13.6% Top Line That Converts to 2.2% Operating Income: Currency, the Regeneron Split, and the 2031 Clock Take Sanofi's Quarter Back